Overview of Boron Neutron Capture Therapy in 2022

In April 2022, the National Cancer Institute of the United States organized a 3-day seminar, dedicated to boron neutron capture therapy (BNCT). This short article summarizes a presentation from that event, which is intended to provide an overview of activities currently underway worldwide to make BNCT available for patient treatments. This overview does not claim to be exhaustive but shows a great deal of activity in all areas necessary for the complex therapy that is BNCT. A rapid increase in the number of BNCT centers can be expected over the next few years, coupled with the introduction of novel drugs for BNCT. It will be a major challenge to all stakeholders to create clinical networks that can conduct the necessary prospective clinical trials in a short time and in high quality.

Automated summary

In April 2022, the National Cancer Institute of the United States hosted a seminar on boron neutron capture therapy (BNCT). This article summarizes a presentation from the event, highlighting the global efforts to make BNCT available for patient treatments. The overview demonstrates the active involvement in various areas necessary for BNCT, with an expected increase in BNCT centers and the introduction of new drugs in the coming years. However, creating efficient clinical networks for timely and high-quality prospective clinical trials will be a major challenge for stakeholders.